Deciphera Pharmaceuticals Inc (DCPH)
25.36
-0.01
(-0.04%)
USD |
NASDAQ |
May 10, 16:00
25.36
0.00 (0.00%)
After-Hours: 20:00
Deciphera Pharmaceuticals Max Drawdown (5Y): 90.18% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 90.18% |
| March 31, 2024 | 90.18% |
| February 29, 2024 | 90.18% |
| January 31, 2024 | 90.18% |
| December 31, 2023 | 90.18% |
| November 30, 2023 | 90.18% |
| October 31, 2023 | 90.18% |
| September 30, 2023 | 90.18% |
| August 31, 2023 | 90.18% |
| July 31, 2023 | 90.18% |
| June 30, 2023 | 90.18% |
| May 31, 2023 | 90.18% |
| April 30, 2023 | 90.18% |
| March 31, 2023 | 90.18% |
| February 28, 2023 | 90.18% |
| January 31, 2023 | 90.18% |
| December 31, 2022 | 90.18% |
| November 30, 2022 | 90.18% |
| October 31, 2022 | 90.18% |
| September 30, 2022 | 90.18% |
| August 31, 2022 | 90.18% |
| July 31, 2022 | 90.18% |
| June 30, 2022 | 90.18% |
| May 31, 2022 | 90.18% |
| April 30, 2022 | 90.18% |
| Date | Value |
|---|---|
| March 31, 2022 | 90.18% |
| February 28, 2022 | 89.32% |
| January 31, 2022 | 88.99% |
| December 31, 2021 | 88.99% |
| November 30, 2021 | 88.99% |
| October 31, 2021 | 62.16% |
| September 30, 2021 | 62.16% |
| August 31, 2021 | 62.16% |
| July 31, 2021 | 57.55% |
| June 30, 2021 | 57.55% |
| May 31, 2021 | 57.55% |
| April 30, 2021 | 57.55% |
| March 31, 2021 | 57.55% |
| February 28, 2021 | 57.55% |
| January 31, 2021 | 57.55% |
| December 31, 2020 | 57.55% |
| November 30, 2020 | 57.55% |
| October 31, 2020 | 57.55% |
| September 30, 2020 | 57.55% |
| August 31, 2020 | 57.55% |
| July 31, 2020 | 57.55% |
| June 30, 2020 | 57.55% |
| May 31, 2020 | 57.55% |
| April 30, 2020 | 57.55% |
| March 31, 2020 | 57.55% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
57.55%
Minimum
May 2019
90.18%
Maximum
Mar 2022
74.02%
Average
75.58%
Median
Max Drawdown (5Y) Benchmarks
| Bristol-Myers Squibb Co | 42.61% |
| Dynavax Technologies Corp | 92.83% |
| Gilead Sciences Inc | 43.18% |
| Esperion Therapeutics Inc | 99.01% |
| SINTX Technologies Inc | 100.00% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -2.378 |
| Beta (5Y) | 0.2001 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 72.61% |
| Historical Sharpe Ratio (5Y) | -0.002 |
| Historical Sortino (5Y) | -0.0031 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 24.88% |